We are live on ! Find out more
SXTPW icon

60 Degrees Pharmaceuticals Warrant
SXTPW

8 hedge funds and large institutions have $30.9K invested in 60 Degrees Pharmaceuticals Warrant in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more capital invested

Capital invested by funds: $17.3K → $30.9K (+$13.6K)

0% more funds holding

Funds holding: 8 → 8 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Mariner
Mariner
Kansas
+$1.96K
2
TSS
Two Sigma Securities
New York
+$547

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$1.06K
2
Citadel Advisors
Citadel Advisors
Florida
-$255
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$14
4
UBS Group
UBS Group
Switzerland
-$1

SXTPW Hedge Fund Activity: Q4 2025 in Review

8 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q4 2025, worth a combined $30.9K — up 78% from $17.3K a quarter earlier.

Fund positioning in SXTPW was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 4 trimmed.

The largest buyer was Mariner, opening a new position worth an estimated $1.96K. The largest seller was Walleye Capital, cutting an estimated $1.06K.

  • 8 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $30.9K of 60 Degrees Pharmaceuticals Warrant stock for Q4 2025, up 78% quarter-over-quarter.
  • 1 fund opened new 60 Degrees Pharmaceuticals Warrant positions in Q4 2025 and 1 closed out, a net change of 0 holders.
  • The largest 60 Degrees Pharmaceuticals Warrant buyer in Q4 2025 was Mariner, an estimated $1.96K added.
  • The largest 60 Degrees Pharmaceuticals Warrant seller in Q4 2025 was Walleye Capital, an estimated $1.06K sold.

Based on aggregated 13F filings for Q4 2025.